piperacillin has been researched along with Kidney Diseases in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (28.57) | 18.7374 |
| 1990's | 8 (28.57) | 18.2507 |
| 2000's | 3 (10.71) | 29.6817 |
| 2010's | 9 (32.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isami, K; Kawamata, Y; Kozono, A; Miyoshi, T; Sasaki, E; Senba, M; Tsumagari, K; Tsuruta, M; Yamashina, T; Yamashita, K | 1 |
| Deresinski, S; Watkins, RR | 1 |
| Keller, F | 1 |
| Burke, MJ; Pratt, JA; Stricherz, MK; Verghese, PS | 1 |
| Akers, KS; Cannon, JW; Chung, KK; Cota, JM; Murray, CK; Niece, KL | 1 |
| Hamaguchi, S; Ikawa, K; Ishihara, N; Karino, F; Kuraki, T; Miura, K; Morikawa, N; Moriyama, H; Nishimura, N; Sutani, A | 1 |
| Arah, OA; Chow, AL; Lye, DC | 1 |
| Mellen, CK; Rindone, JP; Ryba, JE | 1 |
| Alba, LR; Jia, H; Kubin, CJ; Yoko Furuya, E | 1 |
| Al-Ebous, AD; Al-Jahmi, M; Al-Zuriqat, AN; Hiasat, B; Sarayrah, M | 1 |
| Aronoff, GR; Brier, ME; Luft, FC; Sloan, RS | 1 |
| Eron, LJ; Goldenberg, RI; Park, CH; Poretz, DM | 1 |
| Bundtzen, RW; Craig, WA; Gerber, AU; Kwok, FW; Madsen, PO; Welling, PG | 1 |
| Brogden, RN; Heel, RC; Holmes, B; Richards, DM | 1 |
| Capeyron, O; Demotes-Mainard, F; Dupon, M; Janvier, G; Saric, J; Vinçon, G; Winnock, S | 1 |
| Asaka, M; Hashino, S; Imamura, M; Kasai, M; Kobayashi, S; Noto, S; Tanaka, J | 1 |
| Dalla Costa, T; Derendorf, H | 1 |
| Anastasio, P; Casoli, E; De Santo, NG; Molino, D | 1 |
| Amorusi, P; Dowell, JA; Korth-Bradley, J; Milisci, M; Tantillo, K; Tse, S | 1 |
| Dutta, A; Faulkner, R; Greene, DS; Halstenson, CE; Haynes, J; Johnson, CA; Kelloway, JS; Shapiro, BE; Tonelli, A; Zimmerman, SW | 1 |
| Andremont, A; Azab, M; Boutan-Laroze, A; Droz, JP; Kattan, J; Ribrag, V | 1 |
| Goto, M; Iwayama, N; Izuhara, Y; Kusafuka, H; Maeda, K; Obayashi, T; Sezaki, R; Yoshida, H | 1 |
| Chow, AW; Cole, CD; Jewesson, PJ; Kureishi, A; Phillips, GL; Reece, DE; Rubinger, M; Smith, JA | 1 |
| Branch, RA; Sabra, R | 1 |
| Bonsiepe, C; Mondorf, AW; Mondorf, W | 1 |
| Hayashi, T; Katahira, J; Kitayama, R; Kumada, T; Kumano, K; Muratani, T; Saikawa, I; Shimizu, K; Watanabe, Y; Yasuda, T | 1 |
| Hayashi, T; Katahira, J; Kitayama, R; Kumada, T; Kumano, K; Saikawa, I; Shimizu, K; Watanabe, Y; Yasuda, T | 1 |
| De Jongh, CA; Drusano, GL; Finley, RS; Joshi, JH; Moody, MR; Newman, KA; Salvatore, PC; Schimpff, SC; Tenney, JH; Thompson, BW | 1 |
3 review(s) available for piperacillin and Kidney Diseases
| Article | Year |
|---|---|
[Pharmacotherapy and kidney dysfunction].
Topics: Anti-Bacterial Agents; Critical Illness; Glomerular Filtration Rate; Humans; Kidney Diseases; Meropenem; Pharmacokinetics; Piperacillin; Vancomycin | 2019 |
Does Piperacillin-Tazobactam Increase the Risk of Nephrotoxicity when Used with Vancomycin: A Meta-Analysis of Observational Trials.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Kidney Diseases; Observational Studies as Topic; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Vancomycin | 2017 |
Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Topics: Animals; Bacteria; Humans; Intestinal Absorption; Kidney Diseases; Kinetics; Piperacillin; Tissue Distribution | 1984 |
6 trial(s) available for piperacillin and Kidney Diseases
| Article | Year |
|---|---|
Management of diabetic foot in a Jordanian hospital.
Topics: Amikacin; Amputation, Surgical; Anti-Bacterial Agents; Ceftazidime; Chemotherapy, Adjuvant; Debridement; Diabetic Foot; Drug Combinations; Drug Monitoring; Humans; Imipenem; Kidney Diseases; Length of Stay; Lincomycin; Metronidazole; Patient Selection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Severity of Illness Index; Treatment Outcome; Wound Healing; Wound Infection | 2005 |
Evaluating possible pharmacokinetic interactions between tobramycin, piperacillin, and a combination of piperacillin and tazobactam in patients with various degrees of renal impairment.
Topics: Adult; Aged; Aging; Anti-Bacterial Agents; Area Under Curve; beta-Lactamase Inhibitors; Creatinine; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Tobramycin | 2001 |
Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Neoplasms; Neutropenia; Pefloxacin; Piperacillin; Vancomycin | 1992 |
Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Creatinine; Cyclosporine; Double-Blind Method; Drug Interactions; Female; Fever; Glycopeptides; Humans; Kidney Diseases; Male; Middle Aged; Neutropenia; Piperacillin; Teicoplanin; Tobramycin; Vancomycin | 1991 |
Randomized multi center study comparing nephrotoxicity of ceftazidime versus the combination of piperacillin and netilmicin with and without furosemide.
Topics: Aged; Alanine Transaminase; Ceftazidime; Creatinine; Drug Combinations; Female; Furosemide; Humans; Kidney Diseases; Kidney Tubules; Male; Multicenter Studies as Topic; Netilmicin; Piperacillin; Random Allocation; Time Factors | 1989 |
A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Blood Bactericidal Activity; Blood Coagulation Disorders; Clinical Trials as Topic; Drug Hypersensitivity; Drug Synergism; Drug Therapy, Combination; Fever; Hearing Disorders; Humans; Infections; Kanamycin; Kidney Diseases; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation | 1986 |
19 other study(ies) available for piperacillin and Kidney Diseases
| Article | Year |
|---|---|
Investigation of the Efficacy of an Administration Plan for Tazobactam/Piperacillin (TAZ/PIPC) and the Incidence of Kidney and Hepatic Disorders.
Topics: Aged; Aged, 80 and over; Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Chemical and Drug Induced Liver Injury; Creatinine; Drug Administration Schedule; Female; Humans; Incidence; Kidney Diseases; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome | 2017 |
Increasing Evidence of the Nephrotoxicity of Piperacillin/Tazobactam and Vancomycin Combination Therapy-What Is the Clinician to Do?
Topics: Anti-Bacterial Agents; Combined Modality Therapy; Drug Therapy, Combination; Humans; Kidney; Kidney Diseases; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Vancomycin | 2017 |
Suspected piperacillin-tazobactam induced nephrotoxicity in the pediatric oncology population.
Topics: Adolescent; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Kidney Diseases; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prognosis | 2014 |
Modified Augmented Renal Clearance score predicts rapid piperacillin and tazobactam clearance in critically ill surgery and trauma patients.
Topics: Adult; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Critical Illness; Cross-Sectional Studies; Female; Humans; Kidney Diseases; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Wounds and Injuries; Young Adult | 2014 |
Nephrotoxicity induced by piperacillin–tazobactam in late elderly Japanese patients with nursing and healthcare associated pneumonia.
Topics: Aged; Aged, 80 and over; Aging; Anti-Bacterial Agents; Asian People; Cross Infection; Female; Humans; Kidney Diseases; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial | 2014 |
Patient and physician predictors of patient receipt of therapies recommended by a computerized decision support system when initially prescribed broad-spectrum antibiotics: a cohort study.
Topics: Academic Medical Centers; Aged; Anti-Bacterial Agents; Carbapenems; Cohort Studies; Decision Support Systems, Clinical; Drug Therapy, Computer-Assisted; Drug Utilization; Female; Guideline Adherence; Humans; Inappropriate Prescribing; Intensive Care Units; Kidney Diseases; Male; Middle Aged; Patient Admission; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Patterns, Physicians'; Singapore | 2016 |
Lack of significant variability among different methods for calculating antimicrobial days of therapy.
Topics: Adult; Anti-Infective Agents; Ceftriaxone; Drug Dosage Calculations; Humans; Kidney Diseases; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors; Tobramycin; Vancomycin | 2012 |
The effect of piperacillin dose on elimination kinetics in renal impairment.
Topics: Adult; Dose-Response Relationship, Drug; Half-Life; Humans; Kidney Diseases; Kinetics; Penicillins; Piperacillin | 1983 |
Piperacillin therapy for Pseudomonas infections.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Evaluation; Female; Humans; Kidney Diseases; Leukopenia; Male; Middle Aged; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Time Factors; Urinary Tract Infections | 1983 |
Pharmacokinetics of piperacillin in subjects with various degrees of renal function.
Topics: Aged; Dose-Response Relationship, Drug; Humans; Kidney Diseases; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Penicillins; Piperacillin | 1983 |
Plasma levels of piperacillin and vancomycin used as prophylaxis in liver transplant patients.
Topics: Adolescent; Adult; Aged; Bile; Chromatography, High Pressure Liquid; Female; Humans; Kidney Diseases; Liver Transplantation; Male; Middle Aged; Piperacillin; Premedication; Vancomycin | 1993 |
Renal Salmonella enteritidis abscess in a patient with severe aplastic anemia after allogeneic stem cell transplantation.
Topics: Abscess; Adult; Anemia, Aplastic; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Penicillins; Piperacillin; Salmonella enteritidis; Salmonella Infections; Transplantation, Homologous | 1996 |
Pharmacokinetics of piperacillin, tazobactam and its metabolite in renal impairment.
Topics: Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Half-Life; Humans; Kidney Diseases; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam | 1996 |
Renal abscess: recovery without hospitalization and drainage.
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Ceftriaxone; Child; Drainage; Female; Hospitalization; Humans; Kidney; Kidney Diseases; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Radiography; Staphylococcal Infections; Ultrasonography | 2001 |
Single-dose pharmacokinetics of piperacillin and tazobactam in patients with renal disease.
Topics: Adult; beta-Lactamase Inhibitors; Creatine; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; Penicillanic Acid; Peritoneal Dialysis, Continuous Ambulatory; Piperacillin; Renal Dialysis; Tazobactam; Time Factors | 1992 |
[Protective effect by piperacillin against renal impairment caused by amikacin].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Drug Therapy, Combination; Female; Humans; Kidney Diseases; Male; Middle Aged; Piperacillin | 1992 |
Role of sodium in protection by extended-spectrum penicillins against tobramycin-induced nephrotoxicity.
Topics: Animals; Drug Therapy, Combination; Kidney; Kidney Diseases; Male; Penicillins; Piperacillin; Potassium; Rats; Rats, Inbred Strains; Sodium; Ticarcillin; Tobramycin | 1990 |
Protective effect of piperacillin against the nephrotoxicity of cisplatin in rats.
Topics: Animals; Blood Urea Nitrogen; Cisplatin; Fosfomycin; Kidney; Kidney Diseases; Leukemia L1210; Male; Piperacillin; Platinum; Rats; Rats, Inbred F344 | 1989 |
Protective effect of piperacillin against nephrotoxicity of cephaloridine and gentamicin in animals.
Topics: Animals; Cephaloridine; Cephalothin; Fosfomycin; Gentamicins; Kidney Cortex; Kidney Diseases; Kidney Medulla; Male; Piperacillin; Rabbits; Rats; Rats, Inbred Strains | 1988 |